Skip to main content
SpringerLink
Log in

Polymorphisms in the vitamin D receptor and risk of gout in Chinese Han male population

  • Original Article - Genes and Disease
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Previous studies have showed that patients with gout showed lower serum 25(OH)D levels. As the specific receptor of vitamin D, VDR plays an important role in regulating immune system by combining with vitamin D. In this study, we investigated whether the functional VDR polymorphisms were associated with susceptibility to gout in Chinese Han male population. A total of 504 patients with gout and 523 gout-free controls were recruited from the Affiliated Hospital of the Medical College, Qingdao University. Genotyping of VDR rs11568820, rs2228570 and rs1544410 was performed by TaqMan allele discrimination assays. An association analysis was carried out using the χ 2 test. A genotype–phenotype analysis was also conducted. Our results showed that polymorphisms of rs11568820 and rs1544410 in VDR were associated with gout in Chinese Han male population. The A allele of both rs11568820 and rs1544410 was associated with the risk of gout [P = 0.012 OR 1.251, 95 % CI (1.051–1.490); P = 0.006, OR 1.574, 95 % CI (1.139–2.175)]. However, there was no statistic significance between rs2228570 and gout (P = 0.186). Our study suggested that the polymorphisms of VDR may be relevant host susceptibility factors for the development of gout in Chinese Han male population. However, further study should be done in a larger size sample and other ethic to test and verify our result.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Doherty M (2009) New insights into the epidemiology of gout. Rheumatology 48:2–8

    Article  Google Scholar 

  2. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241

    Article  CAS  PubMed  Google Scholar 

  3. Yuan HJ, Yang XG, Shi XY, Tian R, Zhao ZG (2011) Association of serum uric acid with different levels of glucose and related factors. Chin Med J 124:1443–1448

    CAS  PubMed  Google Scholar 

  4. Emmerson B (1998) Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 57:509–510

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Choi HK, De Vera MA, Krishnan E (2008) Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology 47:1567–1570

    Article  CAS  PubMed  Google Scholar 

  6. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  CAS  PubMed  Google Scholar 

  7. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80:1689S–1696S

    CAS  PubMed  Google Scholar 

  8. McCullough ML, Bostick RM, Mayo TL (2009) Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 29:111–132

    Article  CAS  PubMed  Google Scholar 

  9. Hayes ME, Denton J, Freemont AJ, Mawer EB (1989) Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis 48:723–729

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. De Azevedo Silva J, Guimaraes RL, Brandao LA, Araujo J, Segat L et al (2013) Vitamin D receptor (VDR) gene polymorphisms and age onset in type 1 diabetes mellitus. Autoimmunity 46:382–387

    Article  Google Scholar 

  11. Eisman JA (1999) Genetics of osteoporosis. Endocr Rev 20:788–804

    Article  CAS  PubMed  Google Scholar 

  12. Gu JM, Xiao WJ, He JW, Zhang H, Hu WW et al (2009) Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families. Acta Pharmacol Sin 30:1634–1642

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S et al (1995) Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1:1309–1311

    Article  CAS  PubMed  Google Scholar 

  14. Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Yamakita J et al (1998) Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout. Adv Exp Med Biol 431:57–60

    Article  CAS  PubMed  Google Scholar 

  15. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr et al (2005) Gout epidemiology: results from the UK general practice research database, 1990–1999. Ann Rheum Dis 64:267–272

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241

    Article  CAS  PubMed  Google Scholar 

  17. Giamarellos-Bourboulis EJ, Mouktaroudi M, Bodar E, van der Ven J, Kullberg BJ et al (2009) Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Ann Rheum Dis 68:273–278

    Article  CAS  PubMed  Google Scholar 

  18. Landis RC, Haskard DO (2001) Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 3:36–41

    Article  CAS  PubMed  Google Scholar 

  19. Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG (1998) Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 91:1769–1776

    CAS  PubMed  Google Scholar 

  20. di Giovine FS, Malawista SE, Thornton E, Duff GW (1991) Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 87:1375–1381

    Article  PubMed Central  PubMed  Google Scholar 

  21. Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138:3213–3218

    PubMed  Google Scholar 

  22. Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443–1452

    Article  CAS  PubMed  Google Scholar 

  23. Liu S, Yin C, Chu N, Han L, Li C (2013) IL-8-251T/A and IL-12B 1188A/C polymorphisms are associated with gout in a Chinese male population. Scand J Rheumatol 42:150–158

    Article  CAS  PubMed  Google Scholar 

  24. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W et al (2004) Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4:9

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Oda E, Kawai R, Sukumaran V, Watanabe K (2009) Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med 48:1785–1791

    Article  PubMed  Google Scholar 

  26. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S et al (2006) Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19:1055–1062

    Article  CAS  PubMed  Google Scholar 

  27. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD et al (2008) Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. Metab Clin Exp 57:71–76

    Article  CAS  PubMed  Google Scholar 

  28. Rodrigues SL, Baldo MP, Capingana DP, Magalhaes P, Dantas EM et al (2012) Gender distribution of serum uric acid and cardiovascular risk factors: population based study. Arq Bras Cardiol 98:13–21

    Article  CAS  PubMed  Google Scholar 

  29. Hwu CM, Lin KH (2010) Uric acid and the development of hypertension. Med Sci Monit 16:Ra224–Ra230

    CAS  PubMed  Google Scholar 

  30. Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88:491s–499s

    Article  CAS  PubMed  Google Scholar 

  31. Agrawal T, Gupta GK, Agrawal DK (2012) Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation. Exp Mol Pathol 93:74–81

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Sanchez-Nino MD, Bozic M, Cordoba-Lanus E, Valcheva P, Gracia O et al (2012) Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol 302:F647–F657

    Article  CAS  PubMed  Google Scholar 

  33. El-Shal AS, Shalaby SM, Aly NM, Rashad NM, Abdelaziz AM (2013) Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. Mol Biol Rep 40:6063–6073

    Article  CAS  PubMed  Google Scholar 

  34. Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J et al (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45:145–154

    Article  PubMed Central  PubMed  Google Scholar 

  35. Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP, van Leeuwen JPTM (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143–156

    Article  CAS  PubMed  Google Scholar 

  36. Bai YH, Lu H, Hong D, Lin CC, Yu Z et al (2012) Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol 18:1672–1679

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all of the probands for their participation. This work was supported by the National Science Foundation of China (81070686 and 31371272).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Shandong Provincial Key Laboratory of Metabolic Disease and Institute of Clinical Research, The Affiliated Hospital of the Medical College, Qingdao University, Qingdao, People’s Republic of China

    Shi-guo Liu, Yuan-yuan Li, Rui-xia Sun, Xin-de Li, Lin Han & Chang-gui Li

  2. Genetic Laboratory, The Affiliated Hospital of the Medical College, Qingdao University, Qingdao, People’s Republic of China

    Shi-guo Liu & Jing-li Wang

  3. Hiser Hospital, Qingdao, Shandong Province, People’s Republic of China

    Nan Chu

Authors
  1. Shi-guo Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-yuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rui-xia Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing-li Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xin-de Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lin Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nan Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chang-gui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chang-gui Li.

Additional information

Shi-guo Liu and Yuan-yuan Li have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Sg., Li, Yy., Sun, Rx. et al. Polymorphisms in the vitamin D receptor and risk of gout in Chinese Han male population. Rheumatol Int 35, 963–971 (2015). https://doi.org/10.1007/s00296-014-3167-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3167-z

Keywords

Search

Navigation